Journal
LEUKEMIA & LYMPHOMA
Volume 60, Issue 10, Pages 2356-2364Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10428194.2019.1594217
Keywords
Oral therapy; adherence; lymphoma
Categories
Funding
- NCI NIH HHS [K24 CA208132, U01 CA195568] Funding Source: Medline
Ask authors/readers for more resources
Oral therapies have become a common treatment choice for several lymphoid cancers. While therapeutic efficacy and patient preference for this therapy type have been reported, there is a lack of knowledge about its effectiveness for lymphoma in clinical practice, particularly in regard to the effects of medication nonadherence. While studies of oral medications in other diseases have shown that adherence is a major factor in outcomes and costs, there is scant research investigating adherence specifically in lymphoma patients, who face unique challenges in their diseases and treatments. To address the limited data available, we constructed a conceptual model and highlighted key opportunities for future research to better elucidate oral therapy adherence in lymphoma. This research will hopefully improve understanding and efficacy of oral treatment for lymphoma patients, while also informing other cancers utilizing oral therapies currently and in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available